vimarsana.com
Home
Live Updates
Fulgent Reports First Quarter 2024 Financial Results : vimar
Fulgent Reports First Quarter 2024 Financial Results : vimar
Fulgent Reports First Quarter 2024 Financial Results
Total Revenue of $64.5 million
Core Revenue grows 1% year-over-year to $63.2 million
Reiterates Full Year 2024 Core Revenue Guidance of $280 million
...
Related Keywords
United States ,
America ,
Paul Kim ,
Ming Hsieh ,
Exchange Commission ,
Nasdaq ,
Fulgent Genetics Inc ,
Fulgent Genetics ,
Score Revenue ,
Chief Executive Officer ,
Precision Diagnostics ,
Investigational New Drug ,
Chief Financial Officer ,
Investor Relations ,
Private Securities Litigation Reform Act ,
Consolidated Statement ,
Months Ended March ,